CS
BRLI

Credit Suisse’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Credit Suisse’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-59,153
Closed -$2.44M – 4706
2015
Q2 		$2.44M Buy
59,153
+47,973
+429% +$1.72M ﹤0.01% 2385
2015
Q1 		$394K Sell
11,180
-23,002
-67% -$778K ﹤0.01% 3701
2014
Q4 		$1.1M Buy
34,182
+979
+3% +$28.3K ﹤0.01% 3052
2014
Q3 		$931K Sell
33,203
-32,585
-50% -$992K ﹤0.01% 3122
2014
Q2 		$1.99M Buy
65,788
+28,699
+77% +$792K ﹤0.01% 2715
2014
Q1 		$1.03M Sell
37,089
-74,792
-67% -$1.96M ﹤0.01% 3098
2013
Q4 		$2.86M Buy
111,881
+96,275
+617% +$2.97M ﹤0.01% 2350
2013
Q3 		$466K Sell
15,606
-11,367
-42% -$316K ﹤0.01% 3537
2013
Q2 		$776K Buy
+26,973
New +$743K ﹤0.01% 2992

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Credit Suisse's BRLI Position: Q3 2015 in Review

Credit Suisse sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 59,153 shares — an estimated $2.44M sold.

Credit Suisse first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.86M in Q4 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Credit Suisse reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Credit Suisse sold 59,153 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.44M.
  • Credit Suisse first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Credit Suisse's BIO-REFERENCE LABS INC-NEW- position peaked at $2.86M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Credit Suisse's 13F filing for Q3 2015, filed 13 Nov 2015.